Targeting the interleukin‐17 pathway to prevent acute respiratory distress syndrome associated with SARS‐CoV‐2 infection.

Targeting the interleukin-17 pathway to prevent acute respiratory distress syndrome associated with SARS-CoV-2 infection Keywords: acute respiratory distress syndrome; COVID-19; cytokine EN acute respiratory distress syndrome COVID-19 cytokine 797 799 3 07/17/20 20200801 NES 200801 The novel coronavirus causing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19) pandemic. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. [Extracted from the article]